COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies

Background: The novel severe acute respiratory syndrome coronavins 2 (SARS-CoV-2) led to the severe Corona Virus Disease 2019 (COVID-19) outbreak that started in December 2019 in China and caused enormous health and economic problems worldwide. Over time, SARS-CoV-2 has demonstrated the capacity for...

Full description

Bibliographic Details
Main Authors: Jilian Dong, Ruida Chen, Hanhe Zhao, Yirui Zhu
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Advances in Ophthalmology Practice and Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667376222000737
_version_ 1797936287257198592
author Jilian Dong
Ruida Chen
Hanhe Zhao
Yirui Zhu
author_facet Jilian Dong
Ruida Chen
Hanhe Zhao
Yirui Zhu
author_sort Jilian Dong
collection DOAJ
description Background: The novel severe acute respiratory syndrome coronavins 2 (SARS-CoV-2) led to the severe Corona Virus Disease 2019 (COVID-19) outbreak that started in December 2019 in China and caused enormous health and economic problems worldwide. Over time, SARS-CoV-2 has demonstrated the capacity for mutation. As the most prevalent new coronavirus variety worldwide, the Omicron variant has supplanted the Delta variant. The COVID-19 primarily damages the immune system and the lungs, but it can also harm other organs secondarily, depending on the patients' co-existing conditions. Main Text: COVID-19 is associated with ophthalmic manifestations such as conjunctival congestion, tear overflow, and conjunctival edema, with the majority of eye complications occurring in patients with severe infection. The virus may make a patient more susceptible to thrombotic conditions that affect venous and arterial circulation. Meanwhile, it can lead to efferent complications and mucormycosis which is more common in patients with diabetes or who have critical or severe SARS-CoV-2 infection. Significantly, there are a number of ocular side effects following the COVID-19 vaccination, such as herpetic keratitis and facial nerve palsy, which have been reported. These side effects may be caused by the vaccinations' propensity to trigger autoimmune symptoms or thromboembolic events. At present, large-scale nucleic acid testing mainly relies on nasopharyngeal swabs and throat swabs. Tear samples and conjunctival swabs may be helpful samples for the diagnosis of ocular SARS-CoV-2 infection. The eye could be a new route of infection, and finding ways such as effective environmental disinfection, scientific administrative control management, qualified personal protection and other measures to protect the eyes could further reduce the risk of infection. Conclusions: This review aims to sum up the ocular complications of COVID-19, the possible pathogenesis, and preventive strategies to protect ophthalmology practitioners and patients by reviewing the currently available literature on the topic.
first_indexed 2024-04-10T18:27:22Z
format Article
id doaj.art-12e32fa153074c2bb3535c47f6b0111a
institution Directory Open Access Journal
issn 2667-3762
language English
last_indexed 2024-04-10T18:27:22Z
publishDate 2023-02-01
publisher Elsevier
record_format Article
series Advances in Ophthalmology Practice and Research
spelling doaj.art-12e32fa153074c2bb3535c47f6b0111a2023-02-02T04:51:18ZengElsevierAdvances in Ophthalmology Practice and Research2667-37622023-02-01313338COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategiesJilian Dong0Ruida Chen1Hanhe Zhao2Yirui Zhu3School of Public Health, Nanjing Medical University, Nanjing, ChinaEye Department, Affiliated Dongyang Hospital, Wenzhou Medical University, Dongyang, China; Eye Center, Affiliated Second Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaEye Center, Affiliated Second Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaEye Center, Affiliated Second Hospital, School of Medicine, Zhejiang University, Hangzhou, China; Corresponding author. Eye Center, Affiliated Second Hospital, School of Medicine, Zhejiang University, 1 Xihu avenue, Hangzhou, 310009, China.Background: The novel severe acute respiratory syndrome coronavins 2 (SARS-CoV-2) led to the severe Corona Virus Disease 2019 (COVID-19) outbreak that started in December 2019 in China and caused enormous health and economic problems worldwide. Over time, SARS-CoV-2 has demonstrated the capacity for mutation. As the most prevalent new coronavirus variety worldwide, the Omicron variant has supplanted the Delta variant. The COVID-19 primarily damages the immune system and the lungs, but it can also harm other organs secondarily, depending on the patients' co-existing conditions. Main Text: COVID-19 is associated with ophthalmic manifestations such as conjunctival congestion, tear overflow, and conjunctival edema, with the majority of eye complications occurring in patients with severe infection. The virus may make a patient more susceptible to thrombotic conditions that affect venous and arterial circulation. Meanwhile, it can lead to efferent complications and mucormycosis which is more common in patients with diabetes or who have critical or severe SARS-CoV-2 infection. Significantly, there are a number of ocular side effects following the COVID-19 vaccination, such as herpetic keratitis and facial nerve palsy, which have been reported. These side effects may be caused by the vaccinations' propensity to trigger autoimmune symptoms or thromboembolic events. At present, large-scale nucleic acid testing mainly relies on nasopharyngeal swabs and throat swabs. Tear samples and conjunctival swabs may be helpful samples for the diagnosis of ocular SARS-CoV-2 infection. The eye could be a new route of infection, and finding ways such as effective environmental disinfection, scientific administrative control management, qualified personal protection and other measures to protect the eyes could further reduce the risk of infection. Conclusions: This review aims to sum up the ocular complications of COVID-19, the possible pathogenesis, and preventive strategies to protect ophthalmology practitioners and patients by reviewing the currently available literature on the topic.http://www.sciencedirect.com/science/article/pii/S2667376222000737COVID-19Ocular manifestationsDiagnostic toolsPrevention strategies
spellingShingle Jilian Dong
Ruida Chen
Hanhe Zhao
Yirui Zhu
COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies
Advances in Ophthalmology Practice and Research
COVID-19
Ocular manifestations
Diagnostic tools
Prevention strategies
title COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies
title_full COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies
title_fullStr COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies
title_full_unstemmed COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies
title_short COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies
title_sort covid 19 and ocular complications a review of ocular manifestations diagnostic tools and prevention strategies
topic COVID-19
Ocular manifestations
Diagnostic tools
Prevention strategies
url http://www.sciencedirect.com/science/article/pii/S2667376222000737
work_keys_str_mv AT jiliandong covid19andocularcomplicationsareviewofocularmanifestationsdiagnostictoolsandpreventionstrategies
AT ruidachen covid19andocularcomplicationsareviewofocularmanifestationsdiagnostictoolsandpreventionstrategies
AT hanhezhao covid19andocularcomplicationsareviewofocularmanifestationsdiagnostictoolsandpreventionstrategies
AT yiruizhu covid19andocularcomplicationsareviewofocularmanifestationsdiagnostictoolsandpreventionstrategies